I have chronic obstructive pulmonary disease (COPD) and my close contact just tested positive for COVID-19; is there any medication I can be prescribed to prevent me from becoming infected?

No Prophylactic Medication Available for COVID-19 Prevention in COPD Patients

There is currently no medication that can be prescribed to prevent COVID-19 infection in patients with COPD who have been exposed to a positive contact. The available evidence does not support the use of any prophylactic agents for post-exposure prevention in this population.

Key Points for This Patient

What We Know About Prevention

• No proven prophylactic medications exist for preventing COVID-19 after exposure in COPD patients
• The monoclonal antibody combination Tixagevimab + Cilgavimab (Evusheld) showed 88.8% effectiveness for pre-exposure prophylaxis in COPD patients 1, but this was for pre-contact prevention, not post-exposure, and is no longer widely available or recommended in current practice
• Hydroxychloroquine and chloroquine have no evidence supporting their use for COVID-19 prophylaxis 2

What This Patient Should Do Instead

Immediate Actions:

1. Monitor for symptoms - Watch for fever, cough, shortness of breath, or worsening of baseline COPD symptoms
2. Continue all COPD medications - Do not stop or reduce COPD treatments, as disease flares increase infection risk and may require steroids 3
3. Avoid corticosteroid initiation if possible - High-dose steroids (≥20 mg prednisolone daily) are an established risk factor for respiratory tract infections 3

If Symptoms Develop:

• Contact healthcare provider immediately for evaluation
• Early treatment options exist for COVID-19 infection (such as antivirals), but these are for treatment, not prevention
• COPD patients face higher risk of severe COVID-19 complications, including increased exacerbations and mortality 4

Critical Caveat

COPD patients are at significantly higher risk for severe COVID-19 outcomes, including:

• Increased frequency of acute COPD exacerbations after COVID-19 infection 4
• Higher mortality rates (4.6% vs 0% in non-COVID COPD patients) 4
• Greater risk of hospitalization and respiratory failure 5

Practical Recommendation

Since no prophylactic medication is available, focus on:

• Vaccination status - Ensure up-to-date COVID-19 vaccination
• Early symptom recognition - Seek immediate medical attention if symptoms develop to access early treatment options
• COPD optimization - Maintain stable COPD control to minimize baseline risk

The evidence clearly shows that once infected, COPD patients benefit from early antiviral treatment 6, but there is no medication to prevent infection after exposure has occurred.